Search
-
Finance Home
-
Yahoo!
-
Help
[
Latest Headlines
|
Market Overview
|
News Alerts
]
GLAXOSMITHKLINE Company News
LSE:GSK.L
Enter symbol:
symbol lookup
More Info:
Quote
|
Chart
|
News
|
Reports
|
Research
(all times are US Eastern)
Friday, Sep 5, 2008
UPDATE - U.S. FDA lists drugs under safety probes
-
at Reuters
- 8:22 pm
Cymbalta, Tykerb, Tysabri on U.S. drug safety list
-
at Reuters
- 5:10 pm
Thursday, Sep 4, 2008
UPDATE - US FDA staff note deaths in Pfizer bone drug study
-
at Reuters
- 9:18 pm
US FDA staff note deaths in Pfizer bone drug study
-
at Reuters
- 2:28 pm
UPDATE - Merck KGaA, Ablynx link on novel antibody drugs
-
at Reuters
- 1:07 pm
Wednesday, Sep 3, 2008
Glaxo offers corporate plan for its flu drug
-
at Reuters
- 8:23 pm
UPDATE - Almirall, Forest shares tumble after drug setback
-
at Reuters
- 3:56 pm
UPDATE - US approves Novartis generic of Pfizer Genotropin
-
at Reuters
- 12:53 pm
Tuesday, Sep 2, 2008
Glaxo heart drug seen promising despite trial miss
-
at Reuters
- 10:00 am
Sunday, Aug 31, 2008
Fish oil capsules cut death rate in heart failure
-
at Reuters
- 11:30 am
Thursday, Aug 28, 2008
UPDATE - Cervical cancer advances give hope to poor
-
at Reuters
- 5:45 pm
UPDATE - Glaxo signs deal worth up to $820 mln with Valeant
-
at Reuters
- 1:54 pm
Tuesday, Aug 26, 2008
UPDATE - Actelion CEO says new use may double Tracleer sales
-
at Reuters
- 8:40 am
Friday, Aug 22, 2008
UPDATE - U.S. FDA approves Amgen's blood platelet booster
-
at Reuters
- 10:22 pm
Monday, Aug 18, 2008
Chewing gum after surgery may keep you regular
-
at Reuters
- 9:00 pm
European shares fall early, led by banks, drugs
-
at Reuters
- 8:18 am
Wednesday, Aug 13, 2008
More than 80 pct of Indonesia bird flu cases die
-
at Reuters
- 11:30 pm
Thursday, Aug 7, 2008
US patent office tweaks rule amid court fight
-
at Reuters
- 11:16 pm
Wednesday, Jul 23, 2008
GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO
-
PR Newswire
- 3:16 pm
Help
Copyright © 2008 Yahoo! Inc. All Rights Reserved.
Privacy Policy
-
Terms of Service
Questions or Comments?